Medellín, Colombia — 17–19 October 2024 — Genèse Labs has formally entered the Latin American aesthetic-medicine community with its participation in AMWC Colombia 2024, one of the region’s principal academic congress platforms for practitioners, distributors and manufacturers.

Latin America is one of the most dynamic aesthetics markets in the world, characterised by high treatment volumes, strong patient engagement with body contouring and facial rejuvenation, and a practitioner community deeply involved in international academic developments. Colombia in particular functions as a regional hub, drawing physicians from across the continent to its congresses and training programmes. For a European manufacturer, AMWC Colombia provides access to a distribution environment that operates through regional networks rather than individual country-by-country agreements.

Genèse Labs introduced its body-contouring and regenerative portfolio to attendees. In a market with particularly high demand for body treatments, interest in RG60® HA Body Filler was pronounced, with strong regional demand for hip volume augmentation and body shaping aligning precisely with the product’s positioning. The newly launched Proluma™ PDLLA also drew attention: its status as a CE-certified, French-developed collagen stimulator proved a strength in a region where European products command a high degree of trust.

Participation in AMWC Colombia marked the beginning of relationships that developed into sustained regional activity. Genèse Labs has continued to take part in the AMWC Latin America platform, and the region is designated a priority market in the company’s international strategy alongside Europe, Asia and the Middle East.

From October 17–19, 2024, during AMWC Latin America 2024 in Medellín, Colombia, Genèse Labs proudly participated in one of the region’s most dynamic aesthetic-medicine gatherings. The congress drew over 1,500 professional attendees, featured more than 100 international exhibitors, and hosted 90+ thought-leaders and speakers, solidifying its status as a key platform for global aesthetics. (amwc-la.com) At our dedicated booth, Genèse Labs introduced our latest innovations to a highly engaged, multinational audience — highlighting our commitment to combining French brand elegance with Korean manufacturing excellence. The week was filled with meaningful interactions, real-time product demonstrations, and strategic conversations with distributors, clinic owners, and leading aesthetic practitioners from across Latin America and beyond.

We showcased our flagship and emerging product suite: RG60®—our advanced body-volumising filler designed for large-area structural contouring; Proluma™—the PDLLA-based collagen stimulator offering long-lasting regeneration and natural-looking results; and Citrus Bottle—a precision-formulated fat-dissolver featuring Lecithin, Bromelain and Riboflavin to support modern body-shaping treatments. Practitioners appreciated the clarity of our scientific positioning, the elegant packaging aesthetic, and the global availability of our products. The booth became a hub for in-depth discussions around new treatment protocols, cross-regional partnerships, and the evolving needs of the Latin American market.

AMWC Latin America 2024 brought together professionals from more than 30 countries, spanning dermatology, plastic surgery, aesthetic medicine and anti-aging practice. It provided Genèse Labs an ideal context to connect directly with opinion-leaders from Brazil, Mexico, Argentina, Colombia and beyond, secure new distributor agreements for key markets in Latin America, gather on-the-ground insights into regional treatment trends, regulatory nuances and product needs, and emphasize our positioning as a global yet locally responsive aesthetics partner. The high-energy environment, focused networking and real-time feedback reaffirmed the strength of our brand proposition and the readiness of Latin American clinics to adopt premium, scientifically driven aesthetic solutions.

Participation in AMWC Latin America 2024 marks a key milestone in Genèse Labs’ international growth strategy. Building on the global launches of RG60® and Proluma™, this event reinforces our status as a premium partner for professional aesthetics — committed to delivering scientifically advanced, elegantly designed, and globally compliant products. We are proud to stand among the world’s leading aesthetics innovators and look forward to continued expansion into Latin America, the Middle East, Southeast Asia, and beyond.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across the fast-growing fields of body contouring, collagen biostimulation, and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including RG60®, Proluma™, Citrus Bottle™ and the Exoluma™ series — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians, and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.